Strategies For Scaling Up mRNA Manufacturing
Source: Cytiva
The clinical promise of mRNA therapeutics and vaccines is clear, but compared to monoclonal antibodies or viral vectors, their novelty also brings new challenges to the manufacturing process. In this webinar, Cytiva’s Katarina Stenklo will present strategies and technologies for addressing these challenges.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more